Svastia - Precision genome analytics and oncology data collections for pre/clinical studies.

PRODUCTS

Exome and gene panel-based assays for cancer therapy or clinical trial selection (sequencing & clinical reporting) for solid tumors or liquid biopsies.
Check the product catalogue

Clinical report features:

FDA-approved and other clinically relevant mutations – based on ACMG/ASCO guidelines
Applicable to Targeted, Immuno, Chemo, Radio therapies
Genetic consequences for review by oncologists or tumor boards
Biomarkers: Tumor Mutational Burden and Microsatellite Instability, etc.
Exclusive reports for hereditary cancers, relapse and minimal residual disease screening

Clinical trial matching:

Structured clinical-genetic data for clinical trial matching
Data exchange between EHR (HL7-FHIR) and Clinical Trial Management Systems

ORDER A TEST

SEQUENCING AND ANALYTICS

Svastia offers a wide range of sequencing services, including RNASeq, exome or gene panels, B/T-Cell repertoire and tailored services for therapeutic antibodies. Advanced bioinformatics and biomarker analytics enable clinical decision support and patient screening for clinical trials [more..]

DRUG EFFICACY SCREENING

Cell-based drug efficacy screening, using standard or genetically modified cell lines bundled with an interactive portal to enable genetics-aided cell line selection and bioinformatic analysis [more..]

DATA COLLECTION SERVICE

Svastia offers a bespoke data collection service through its network of hospitals. Our clinical and genetic data collections follow global standards for patient consent, data security and ethics [more..]

THERAPEUTIC ANTIBODY TOOLKIT

Svastia offers an independent platform for antibody drug development using phage- or other display technologies as well as next-gen sequencing of immune repertoires. Due to the sensitive nature of novel molecules, Svastia offers the flexibility of hosting the platform in-house or in private cloud environments. [more..]

siRNA TARGET FINDER

Our siRNA design service offers a design tool combined with data consulting to choose potent functional siRNAs, by reviewing physical, conservational and other biological parameters especially for difficult targets. [more..]